Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,082 shares at $109.98 ($339K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Seasonal sale ($339k) by Chief Business Development Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.98 | 1,541 | $169K | 50.0% |
| 2 | $109.98 | 1,541 | $169K | 50.0% |
| Total | $109.98 avg | 3,082 | $339K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |